Welcome to our dedicated page for scPharmaceuticals SEC filings (Ticker: SCPH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
scPharmaceuticals Inc. filings document material-event disclosures for a cardiorenal pharmaceutical issuer, including common stock registration, material agreements, financing arrangements, governance matters, and corporate-status records. Form 8-K reports cover definitive agreement disclosures and an unsecured promissory note, while exchange-related filings identify SCPH common stock as the registered security.
The filing record includes a Form 25 notification by Nasdaq for removal of the company's common stock from exchange listing and Section 12(b) registration. These filings provide formal records of SCPH's capital structure, listing status, contractual obligations, and public-company governance transition.